AAAAAA

   
Results: 1-9 |
Results: 9
DETECTION OF CBF-BETA MYH11 FUSION TRANSCRIPTS IN PATIENTS WITH INV(16) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/
Authors: ELMAAGACLI AH BEELEN DW KROLL M TRZENSKY S STEIN C SCHAEFER UW
Citation: Ah. Elmaagacli et al., DETECTION OF CBF-BETA MYH11 FUSION TRANSCRIPTS IN PATIENTS WITH INV(16) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/, Bone marrow transplantation, 21(2), 1998, pp. 159-166
A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ELMAAGACLI AH BEELEN DW SCHAEFER UW
Citation: Ah. Elmaagacli et al., A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 236-236
A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: ELMAAGACLI AH BEELEN DW SCHAEFER UW
Citation: Ah. Elmaagacli et al., A RETROSPECTIVE SINGLE-CENTER STUDY OF THE OUTCOME OF 5 DIFFERENT THERAPY APPROACHES IN 48 PATIENTS WITH RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1045-1055
DETECTION OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/
Authors: ELMAAGACLI AH BEELEN DW STOCKOVA J TRZENSKY S KROLL M SCHAEFER UW STEIN C OPALKA B
Citation: Ah. Elmaagacli et al., DETECTION OF AML1 ETO FUSION TRANSCRIPTS IN PATIENTS WITH T(8-21) ACUTE MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION/, Blood, 90(8), 1997, pp. 3230-3231
MOLECULAR STUDIES OF CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL OR BONE-MARROW TRANSPLANTATION
Authors: ELMAAGACLI AH BEELEN DW BECKS HW MOBASCHER A STOCKOVA J TRZENSKY S OPALKA B SCHAEFER UW
Citation: Ah. Elmaagacli et al., MOLECULAR STUDIES OF CHIMERISM AND MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL OR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(2), 1996, pp. 397-403
COMPARISON OF THE INCIDENCE OF HOST-TYPE HEMATOPOIESIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER SEX MISMATCHED, NON-T-CELL DEPLETED, ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT)
Authors: ELMAAGACLI AH BECKS HW BEELEN DW MOBASCHER A STOCKOVA J SCHAEFER UW
Citation: Ah. Elmaagacli et al., COMPARISON OF THE INCIDENCE OF HOST-TYPE HEMATOPOIESIS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER SEX MISMATCHED, NON-T-CELL DEPLETED, ALLOGENEIC BONE-MARROWTRANSPLANTATION (BMT), Experimental hematology, 23(8), 1995, pp. 854-854
DETECTION OF MINIMAL RESIDUAL DISEASE AND PERSISTENCE OF HOST-TYPE HEMATOPOIESIS - A STUDY IN 28 PATIENTS AFTER SEX-MISMATCHED, NON-T CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
Authors: ELMAAGACLI AH BECKS HW BEELEN DW STOCKOVA J BUTZLER R OPALKA B SCHAEFER UW
Citation: Ah. Elmaagacli et al., DETECTION OF MINIMAL RESIDUAL DISEASE AND PERSISTENCE OF HOST-TYPE HEMATOPOIESIS - A STUDY IN 28 PATIENTS AFTER SEX-MISMATCHED, NON-T CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 16(6), 1995, pp. 823-829
PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME
Authors: BEELEN DW GRAEVEN U ELMAAGACLI AH NIEDERLE N KLOKE O OPALKA B SCHAEFER UW
Citation: Dw. Beelen et al., PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME, Blood, 85(10), 1995, pp. 2981-2990
INTERFERON-ALPHA AND GAMMA ALTER THE BINDING OF PROGENITOR CELLS TO FIBRONECTIN OF PATIENTS WITH CML
Authors: ELMAAGACLI AH WANDL UB BERTHEL M KIRCH HC SCHAEFER UW
Citation: Ah. Elmaagacli et al., INTERFERON-ALPHA AND GAMMA ALTER THE BINDING OF PROGENITOR CELLS TO FIBRONECTIN OF PATIENTS WITH CML, Leukemia, 7(8), 1993, pp. 1300-1301
Risultati: 1-9 |